Metformin Causes G1-Phase Arrest via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity through DR5 Up-Regulation in Pancreatic Cancer Cells
about
Role of MicroRNAs-221/222 in Digestive SystemsMetformin Increases Sensitivity of Pancreatic Cancer Cells to Gemcitabine by Reducing CD133+ Cell Populations and Suppressing ERK/P70S6K Signaling.Analysis of MicroRNA Expression Profiles in Weaned Pig Skeletal Muscle after Lipopolysaccharide Challenge.Metformin Induces Growth Inhibition and Cell Cycle Arrest by Upregulating MicroRNA34a in Renal Cancer Cells.Potential Value of miR-221/222 as Diagnostic, Prognostic, and Therapeutic Biomarkers for Diseases.Ellagic acid inhibits the proliferation of human pancreatic carcinoma PANC-1 cells in vitro and in vivoGastric bypass surgery with exercise alters plasma microRNAs that predict improvements in cardiometabolic risk.The expanding role of metformin in cancer: an update on antitumor mechanisms and clinical development.Mir-221/222 are promising targets for innovative anticancer therapy.Effects of resveratrol, curcumin, berberine and other nutraceuticals on aging, cancer development, cancer stem cells and microRNAs.Metformin induces apoptosis of human hepatocellular carcinoma HepG2 cells by activating an AMPK/p53/miR-23a/FOXA1 pathway.Metformin sensitizes triple-negative breast cancer to proapoptotic TRAIL receptor agonists by suppressing XIAP expression.lncRNA GAS5 Reverses EMT and Tumor Stem Cell-Mediated Gemcitabine Resistance and Metastasis by Targeting miR-221/SOCS3 in Pancreatic Cancer
P2860
Q26799877-C7EE12C9-5233-46FF-A1A5-C1EFB81DFBF1Q36099266-9A86262A-7CE2-41B7-BF73-6DA8554D287EQ36184243-E1064DDC-9241-4654-8221-F90244883EB8Q37579970-EA09DFD3-E2A4-4F56-A33A-760943F1920DQ37643929-806B6CFB-45F5-4B62-A549-77B0672C7992Q37707090-363487A0-DFCC-4F8E-9260-07BCF7671CE2Q38378978-C3D4CF3D-3BC4-4D25-A1EC-6FCD9A83BED9Q38728567-64118121-42C2-4F6E-BEA5-990EEDB9A492Q38767024-94C8C4F5-6F54-4F47-B58D-B601E47064CCQ39370677-7D6A3FE7-1B83-4240-AA9D-E5BE11C7B6C9Q40641258-BA4671D4-54BA-4E5C-B1A7-DB32857C8B00Q48096856-89FC41A3-CB06-435A-AB6D-17683B550B27Q58581562-69E15DE0-D0CD-4E67-8828-D0CD556A7BBC
P2860
Metformin Causes G1-Phase Arrest via Down-Regulation of MiR-221 and Enhances TRAIL Sensitivity through DR5 Up-Regulation in Pancreatic Cancer Cells
description
2015 nî lūn-bûn
@nan
2015 թուականին հրատարակուած գիտական յօդուած
@hyw
2015 թվականին հրատարակված գիտական հոդված
@hy
2015年の論文
@ja
2015年論文
@yue
2015年論文
@zh-hant
2015年論文
@zh-hk
2015年論文
@zh-mo
2015年論文
@zh-tw
2015年论文
@wuu
name
Metformin Causes G1-Phase Arre ...... ion in Pancreatic Cancer Cells
@ast
Metformin Causes G1-Phase Arre ...... ion in Pancreatic Cancer Cells
@en
Metformin Causes G1-Phase Arre ...... ion in Pancreatic Cancer Cells
@nl
type
label
Metformin Causes G1-Phase Arre ...... ion in Pancreatic Cancer Cells
@ast
Metformin Causes G1-Phase Arre ...... ion in Pancreatic Cancer Cells
@en
Metformin Causes G1-Phase Arre ...... ion in Pancreatic Cancer Cells
@nl
prefLabel
Metformin Causes G1-Phase Arre ...... ion in Pancreatic Cancer Cells
@ast
Metformin Causes G1-Phase Arre ...... ion in Pancreatic Cancer Cells
@en
Metformin Causes G1-Phase Arre ...... ion in Pancreatic Cancer Cells
@nl
P2093
P2860
P3181
P1433
P1476
Metformin Causes G1-Phase Arre ...... ion in Pancreatic Cancer Cells
@en
P2093
Mano Horinaka
Mitsuhiro Tomosugi
Ryoichi Tanaka
Toshiyuki Sakai
Yoshihiro Sowa
P2860
P304
P3181
P356
10.1371/JOURNAL.PONE.0125779
P407
P577
2015-01-01T00:00:00Z